Protara Therapeutics Inc.
Organization details
- Legal name
- Protara Therapeutics Inc.
- Former names
- ArTara Therapeutics, Inc. Proteon Therapeutics Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TARA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001359931
- EIN
- 20-4580525
- Wikidata ID
- Q7251543
Board of directors
-
Barry P. Flannelly · DirectorSince 2023
- Since 2023
-
Gregory Sargen · DirectorSince 2023
-
Jane Huang · DirectorSince 2023
-
Jesse Shefferman · Director · CEO and PresidentSince 2023
-
Luke M. Beshar · DirectorSince 2023
-
Michael Edward Solomon · DirectorSince 2023
-
Richard S. Levy · DirectorSince 2023
-
Roger Garceau · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
72.4%
-
86.3%
Board connections
3 of this board's directors also sit on 8 other boards. 8 are in the same sector.
-
Agios Pharmaceuticals Inc. Same sectorvia Cynthia Smith
-
Akebia Therapeutics Inc. Same sectorvia Cynthia Smith
-
Entera Bio Ltd. Same sectorvia Roger Garceau
-
Kiniksa Pharmaceuticals International plc Same sectorvia Richard S. Levy
-
Kodiak Sciences Inc Same sectorvia Richard S. Levy
-
Madrigal Pharmaceuticals Inc. Same sectorvia Richard S. Levy
-
Spero Therapeutics Inc. Same sectorvia Cynthia Smith
-
Tvardi Therapeutics Inc. Same sectorvia Cynthia Smith
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,007,149
- 3 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jesse Shefferman Director, Officer (CEO and President) | Gift | −14,000 | — | — |
| Jun 30, 2026 | Jesse Shefferman Director, Officer (CEO and President) | Gift | −7,000 | — | — |
| Jun 30, 2026 | Jesse Shefferman Director, Officer (CEO and President) | Gift | −4,000 | — | — |
| Jun 30, 2026 | Jesse Shefferman Director, Officer (CEO and President) | Gift | −5,000 | — | — |
| Jun 29, 2026 | Jesse Shefferman Director, Officer (CEO and President) | Option exercise | +215,687 | $1.91 | $411,962 |
| Jun 29, 2026 | Jesse Shefferman Director, Officer (CEO and President) | Open-market sale | −215,687 | $4.09 | $882,160 |
| Jun 2, 2026 | William Conkling Officer (Chief Commercial Officer) | Shares withheld for tax | −6,008 | $4.34 | $26,075 |
| Apr 8, 2026 | Zummo Jacqueline Officer (Chief R&D Officer) | Open-market sale | −1,134 | $5.40 | $6,124 |
| Apr 1, 2026 | Zummo Jacqueline Officer (Chief R&D Officer) | Open-market sale | −22,598 | $5.26 | $118,865 |
| Jan 26, 2026 | Jesse Shefferman Director, Officer (CEO and President) | Shares withheld for tax | −8,732 | $6.67 | $58,242 |
| Jan 26, 2026 | Zummo Jacqueline Officer (Chf Scientific Operations Off) | Shares withheld for tax | −3,724 | $6.67 | $24,839 |
| Jan 26, 2026 | Fry Hannah Officer (VP, Controller) | Shares withheld for tax | −1,457 | $6.67 | $9,718 |
| Jan 26, 2026 | Patrick Fabbio Officer (Chief Financial Officer) | Shares withheld for tax | −3,261 | $6.67 | $21,751 |
| Jan 20, 2026 | Jesse Shefferman Director, Officer (CEO and President) | Shares withheld for tax | −16,322 | $5.60 | $91,403 |
| Jan 20, 2026 | Patrick Fabbio Officer (Chief Financial Officer) | Shares withheld for tax | −3,063 | $5.60 | $17,153 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Protara Therapeutics Inc.
Who is the CEO of Protara Therapeutics Inc.?
Jesse Shefferman is Protara Therapeutics Inc.'s CEO and President.
How many directors are on Protara Therapeutics Inc.'s board?
Protara Therapeutics Inc.'s board has 9 directors: Barry P. Flannelly, Cynthia Smith, Gregory Sargen, Jane Huang, Jesse Shefferman, Luke M. Beshar, Michael Edward Solomon, Richard S. Levy and Roger Garceau.
Are Protara Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Protara Therapeutics Inc. insiders made no open-market purchases and sold $1.0 million of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="protara-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.